This review focuses on one of these entities, specifically the phenotypic spectrum of patients diagnosed with GATA2 deficiency, recognized as a major myeloid neoplasia predisposition syndrome with pleiotropic manifestations. The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.